iHuman Inc. (IH) Financial Ratios
7 years of historical data (2018–2024) · Consumer Defensive · Education & Training Services
EV/EBITDA
↓
-11.77
—
5yr avg: N/A
P/FCF
↓
1.98
↑+54% vs avg
5yr avg: 1.28
30Y Low0.0·High5.0
P/B Ratio
↓
0.11
↑+33% vs avg
5yr avg: 0.08
30Y Low0.0·High0.3
ROE
↑
10.3%
↓+75% vs avg
5yr avg: 5.9%
30Y Low-12%·High21%
Debt/EBITDA
↑
0.17
↑+93% vs avg
5yr avg: 0.09
30Y Low0.0·High0.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
IH Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
iHuman Inc. trades at 1.0x earnings, 394% above its 5-year average of 0.2x, sitting at the 100th percentile of its historical range. Compared to the Consumer Defensive sector median P/E of 18.8x, the stock trades at a discount of 94%. On a free-cash-flow basis, the stock trades at 2.0x P/FCF, 54% above the 5-year average of 1.3x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $15M | $18M | $34M | $28M | $30M | $164M | — | — |
| Enterprise Value | $-148829027 | $-1090045880 | $-1176288658 | $-1012880680 | $-791253440 | $-691016768 | — | — |
| P/E Ratio → | 1.04 | 0.19 | 0.19 | 0.26 | — | — | — | — |
| P/S Ratio | 0.11 | 0.02 | 0.03 | 0.03 | 0.03 | 0.31 | — | — |
| P/B Ratio | 0.11 | 0.02 | 0.04 | 0.04 | 0.05 | 0.26 | — | — |
| P/FCF | 1.98 | 0.36 | 0.20 | 0.02 | 5.03 | 0.79 | — | — |
| P/OCF | 1.73 | 0.31 | 0.20 | 0.02 | 0.78 | 0.74 | — | — |
P/E links to full P/E history page with 30-year chart
IH EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | -1.18 | -1.16 | -1.03 | -0.84 | -1.30 | — | — |
| EV / EBITDA | -11.77 | -12.74 | -6.86 | -8.27 | — | — | — | — |
| EV / EBIT | -14.01 | -15.16 | -7.36 | -9.08 | — | — | — | — |
| EV / FCF | — | -21.33 | -7.10 | -0.81 | -133.41 | -3.34 | — | — |
IH Profitability
Margins and return-on-capital ratios measuring operating efficiency
iHuman Inc. earns an operating margin of 7.8%, above the Consumer Defensive sector average of 3.5%. Operating margins have compressed from 11.3% to 7.8% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 10.3% is modest.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 69.4% | 70.8% | 70.1% | 69.9% | 68.7% | 61.5% | 50.1% |
| Operating Margin | 7.8% | 7.8% | 15.7% | 11.3% | -5.7% | -8.4% | -127.5% | -16.7% |
| Net Profit Margin | 10.7% | 10.7% | 17.8% | 11.1% | -3.9% | -7.0% | -126.0% | -13.3% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| ROE | 10.3% | 10.3% | 20.9% | 15.9% | -5.9% | -11.9% | — | — |
| ROA | 6.9% | 6.9% | 13.0% | 9.0% | -3.5% | -6.2% | -242.9% | -30.0% |
| ROIC | — | — | — | — | — | — | — | — |
| ROCE | 7.4% | 7.4% | 18.5% | 16.1% | -8.6% | -14.0% | — | — |
IH Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
iHuman Inc. carries a Debt/EBITDA ratio of 0.2x, which is very conservative (95% below the sector average of 3.5x). The company holds a net cash position — cash of $1.1B exceeds total debt of $15M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.00 | 0.01 | 0.06 | 0.01 | — | — |
| Debt / EBITDA | 0.17 | 0.17 | 0.02 | 0.07 | — | — | — | — |
| Net Debt / Equity | — | -1.15 | -1.26 | -1.35 | -1.35 | -1.33 | — | — |
| Net Debt / EBITDA | -12.95 | -12.95 | -7.05 | -8.50 | — | — | — | — |
| Debt / FCF | — | -21.69 | -7.31 | -0.84 | -138.44 | -4.13 | -2.61 | — |
| Interest Coverage | — | — | — | — | — | — | — | — |
Net cash position: cash ($1.1B) exceeds total debt ($15M)
IH Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
iHuman Inc.'s current ratio of 2.98x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.23x to 2.98x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.98 | 2.98 | 2.82 | 2.23 | 2.10 | 2.56 | 0.89 | 0.47 |
| Quick Ratio | 2.93 | 2.93 | 2.78 | 2.20 | 2.04 | 2.52 | 0.78 | 0.23 |
| Cash Ratio | 2.61 | 2.61 | 2.47 | 1.87 | 1.77 | 2.16 | 0.57 | 0.05 |
| Asset Turnover | — | 0.65 | 0.70 | 0.74 | 0.86 | 0.51 | 1.30 | 2.25 |
| Inventory Turnover | 12.01 | 12.01 | 17.97 | 15.39 | 10.13 | 9.87 | 4.07 | 2.22 |
| Days Sales Outstanding | — | 21.40 | 22.46 | 30.33 | 22.79 | 53.72 | 35.03 | 37.71 |
IH Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
iHuman Inc. returns 44.4% to shareholders annually — split between a 34.8% dividend yield and 9.5% buyback yield. The payout ratio of 35.8% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 96.5% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 34.8% | 100.0% | — | — | — | 40.2% | — | — |
| Payout Ratio | 35.8% | 35.8% | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 96.5% | 532.5% | 537.5% | 390.4% | — | — | — | — |
| FCF Yield | 50.5% | 278.7% | 492.6% | 4434.8% | 19.9% | 126.2% | — | — |
| Buyback Yield | 9.5% | 52.5% | 28.4% | 24.8% | 0.5% | 0.0% | — | — |
| Total Shareholder Yield | 44.4% | 100.0% | 28.4% | 24.8% | 0.5% | 40.2% | — | — |
| Shares Outstanding | — | $11M | $11M | $11M | $11M | $9M | $11M | $11M |
Peer Comparison
Compare IH with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 IHYou | $15M | 1.0 | -11.8 | 2.0 | 69.4% | 7.8% | 10.3% | — | 0.2 |
 GOTU | $599M | -13.3 | — | 16.4 | 67.4% | -8.2% | -20.3% | -33.8% | — |
 COE | $2M | -0.1 | — | 0.2 | 73.9% | -15.1% | — | — | — |
 TAL | $621M | 7.3 | -20.0 | 2.2 | 53.3% | -0.3% | 2.3% | -0.3% | 8.2 |
 EDU | $7B | 19.6 | 11.9 | 11.2 | 55.4% | 8.7% | 9.3% | 9.9% | 1.5 |
 DAO | $1B | 90.6 | 43.8 | — | 44.3% | 3.9% | — | — | 7.3 |
 FEDU | $2M | 17.6 | — | — | 18.8% | -6.3% | 0.2% | -3.0% | — |
 BILI | $7B | 44.9 | 14.0 | 9.2 | 36.6% | 3.7% | 8.0% | 7.7% | 2.9 |
 BIDU | $38B | 64.3 | 39.3 | — | 43.9% | -4.5% | 1.9% | -1.2% | 11.6 |
 NTES | $77B | 15.7 | 12.6 | 10.8 | 64.3% | 31.8% | 21.9% | 24.0% | 0.2 |
 DUOL | $6B | 14.7 | 32.7 | 15.8 | 72.2% | 13.1% | 38.1% | 40.8% | 0.6 |
| Consumer Defensive Median | — | 18.8 | 11.0 | 15.3 | 40.8% | 3.5% | 6.5% | 5.7% | 3.5 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
IH — Frequently Asked Questions
Quick answers to the most common questions about buying IH stock.
What is iHuman Inc.'s P/E ratio?
iHuman Inc.'s current P/E ratio is 1.0x. The historical average is 0.2x. This places it at the 100th percentile of its historical range.
What is iHuman Inc.'s EV/EBITDA?
iHuman Inc.'s current EV/EBITDA is -11.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA.
What is iHuman Inc.'s ROE?
iHuman Inc.'s return on equity (ROE) is 10.3%. The historical average is 5.9%.
Is IH stock overvalued?
Based on historical data, iHuman Inc. is trading at a P/E of 1.0x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What is iHuman Inc.'s dividend yield?
iHuman Inc.'s current dividend yield is 34.85% with a payout ratio of 35.8%.
What are iHuman Inc.'s profit margins?
iHuman Inc. has 69.4% gross margin and 7.8% operating margin.
How much debt does iHuman Inc. have?
iHuman Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.